Table 2 10-year overall and cancer-specific survival after a testicular cancer diagnosis. Geneva 1970–2012
Overall | Specific | |||||
|---|---|---|---|---|---|---|
% surviving | 95% CI | Log-rank | % surviving | 95% CI | Log-rank | |
All patients | 87% | [84–90] | 92% | [89–94] | ||
By period | ||||||
1970–79 | 65% | [54–75] | < 0.001 | 70% | [59–79] | < 0.001 |
1980–89 | 86% | [78–91] | 93% | [86–96] | ||
1990–99 | 94% | [88–97] | 96% | [91–98] | ||
2000–12 | 94% | [87–97] | 97% | [93–99] | ||
Patients diagnosed 1990–2012 | 94% | [90–96] | 96% | [93–98] | ||
By age | ||||||
≤ 29 | 94% | [86–98] | 0.015 | 96% | [90–99] | 0.440 |
30–39 | 97% | [91–99] | 98% | [94–100] | ||
40–49 | 94% | [83–98] | 94% | [83–98] | ||
50+ | 83% | [61–93] | 94% | [79–99] | ||
By social class | ||||||
High | 94% | [85–98] | 0.182 | 98% | [91–99] | 0.078 |
Medium | 97% | [91–99] | 98% | [94–100] | ||
Low | 88% | [77–94] | 90% | [79–95] | ||
Unknown | 91% | [65–98] | 97% | [81–1.00] | ||
By stage | ||||||
I | 96% | [92–98] | < 0.001 | 99% | [96–100] | < 0.001 |
II | 93% | [74–98] | 95% | [72–99] | ||
III | 81% | [67–90] | 81% | [67–90] | ||
Unknown | – | – | 100% | – | ||
By morphology | ||||||
Seminoma | 96% | [91–98] | 0.014 | 98% | [94–100] | < 0.001 |
Non-seminoma | 90% | [83–95] | 93% | [87–96] | ||